Evidence map›Paper›PMID 36655070›Full record

ArticleFood science & nutrition2023

Formulation optimization of functional wheat bread with low glycemic index from technological and nutritional perspective.

Neda Mollakhalili-Meybodi, Mohammad Hassan Ehrampoush, Bahador Hajimohammadi, Mohammad Hassan Mosaddegh

Abstract read
In one paragraph

Article in Food science & nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Neda Mollakhalili-MeybodiDepartment of Food Science and Technology School of Public Health Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0001-8473-7517
Mohammad Hassan EhrampoushEnvironmental Science and Technology Research Center Department of Environmental Health Engineering School of Public Health Shahid Sadoughi University of Medical Sciences Yazd Iran.
Bahador HajimohammadiResearch Center for Food Hygiene and Safety Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0003-4463-5465
Mohammad Hassan MosaddeghDepartment of Pharmacology School of Pharmacy Shahid Sadoughi University of Medical Sciences Yazd Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inclusion of prebiotic compounds as indigestible dietary fiber in wheat bread has grown rapidly considering the increased public awareness about their impact on health. However, through their incorporation, the technological characteristics may adversely be influenced by gluten dilution impacts. This study was done to evaluate the impacts of long chain, native and short chain inulin (L-, N-, and S-type inulin, respectively) at 8%, 10%, 12%, 14%, and 16% w/w as Inulin Reconstituted Wheat Flour (IRWF) with similar gluten: carbohydrate ratio of wheat flour (at 10%, 12.5%, 15%, 17.5%, 20% w/w) on technological and nutritional value of wheat bread. Results indicated that despite no gluten dilution induced by IRWF supplementation, technological characteristics were adversely influenced especially at higher substitution level of L-type-containing formulations which is attributed to their higher water absorption index (WAI). Reversely, the nutritional value was positively influenced in which the lowest hydrolysis index (26.64%); predicted Glycemic Index (51.93%) and fructan loss content (25.42%) were found at L-type inulin-containing IRWF at the highest substitution level (20% w/w). As the nutritional value of wheat bread as staple foodstuff is important, optimizing the bread-making process to decrease all reverse impacts induced by L-inulin-type inclusion seems to be required.

Indexed as

inulinnutritionalreconstitutionsupplementationtechnologicalwheat bread

Identifiers

PMID36655070
PMCPMC9834865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.